HIV/AIDS News

Global mortality rates are decreasing but not among children, adolescents and young adults, according to study results published in The Lancet.

Healio received an APEX award for a 2024 report on the cloudy future of HIV vaccine research in the age of long-acting injectable medications that can protect people from the virus for months at a time.

Long-acting lenacapavir has been shown to be a promising option for HIV PrEP and is now recommended globally by WHO, with a recent licensing agreement ensuring accelerated access to countries in need.

The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with Trump administration priorities, but will apparently leave one critical public health program alone.

Cuts to U.S. foreign aid will endanger HIV treatment and prevention services globally and are likely to reverse decades of progress against the virus, researchers said this week.

The FDA on Wednesday approved a highly effective long-acting shot for HIV prevention that is administered just twice per year, greatly extending the time people can go between doses of a medication that protects them from the virus.

Infectious disease clinicians raised alarm that proposed cuts to Medicaid could affect ID-related services, not only among patients using the program but also patients with private health insurance.

HHS is rehiring hundreds of people fired from their positions at the CDC during initial government downsizing efforts earlier this year, the department confirmed to Healio.

SAN FRANCISCO — The use of mobile health care units that distribute ART and PrEP medications increased uptake among people who inject drugs, a population at greater risk for acquiring HIV, according to a study.